Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma

被引:0
作者
Qiancheng Shi
Ning Liu
Lei Yang
Yi Chen
Yanwen Lu
Hongqian Guo
Xiaodong Han
Dongmei Li
Weidong Gan
机构
[1] Medical School of Nanjing University,Department of Urology, Affiliated Drum Tower Hospital
[2] Nanjing First Hospital,Department of Urology
[3] Nanjing Medical University,Immunology and Reproduction Biology Laboratory and State Key Laboratory of Analytical Chemistry for Life Science, Medical School
[4] Nanjing University,Jiangsu Key Laboratory of Molecular Medicine
[5] Nanjing University,undefined
来源
Cell Communication and Signaling | / 19卷
关键词
Renal cell carcinoma; Xp11.2; Estradiol; Estrogen receptor; Topoisomerase; TFE3;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 296 条
[1]  
de Jong B(1988)Cytogenetics of 12 cases of renal adenocarcinoma Cancer Genet Cytogenet 30 53-61
[2]  
Oosterhuis JW(2015)MiT family translocation renal cell carcinoma Semin Diagn Pathol 32 103-113
[3]  
Idenburg VJ(2015)Characterization of adolescent and pediatric renal cell carcinoma: a report from the Children's Oncology Group study AREN03B2 Cancer 121 2457-2464
[4]  
Castedo SM(2012)Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect Histol Histopathol 27 133-140
[5]  
Dam A(2019)MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge Cancers 11 1110-1160
[6]  
Mensink HJ(2007)Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum Am J Surg Pathol 31 1149-E76
[7]  
Argani P(2011)Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome BJU Int 108 E71-886
[8]  
Geller JI(2014)Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage Modern Pathol 27 875-3252
[9]  
Ehrlich PF(2015)Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review Future Oncol (London, England). 11 3243-30
[10]  
Cost NG(2016)Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies BMC Urol 16 40-1534